CIK 0001762303
- Non-accelerated filer
- Smaller reporting company
AVITA Medical, Inc.
Sign in to watch- Tickers
- RCEL AVHHL
- Exchange
- Nasdaq, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202578762
- Phone
- +1 661-568-1317
- Business address
- 28159 AVENUE STANFORD, SUITE 220, VALENCIA, CA, 91355
- Former names
- Avita Therapeutics, Inc., Avita Medical, Ltd.
Securities
- RCEL Common Stock Nasdaq
- AVHHL Common stock OTC
- 4 Open-market buy CFO bought 500 shares at $10.68 ($5,340)
- 4 Open-market buy CFO bought 2,000 shares at an average $10.28 ($20,560)
- 4 Open-market buy CFO bought 2,000 shares at an average $12.30 ($24,600)
- 4 Open-market buy CFO bought 2,000 shares at an average $13.07 ($26,130)
- 4 Open-market sale General Counsel sold 4,193 shares at $15.84 ($66,417)
- 4 Open-market buy CFO bought 2,000 shares at an average $17.06 ($34,110)
- 4 Open-market buy CFO bought 5,000 shares at an average $17.93 ($89,640)
- 4 Open-market buy CFO bought 1,000 shares at $16.15 ($16,150)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 16,549 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 6,175 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 6,175 shares (grant or award)
- 4 Grant or award Director acquired 16,549 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 6,175 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 6,175 shares (grant or award)
Page 4 of 7 · 140 filings